Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 8:01 PM
Ignite Modification Date:
2025-12-24 @ 8:01 PM
NCT ID:
NCT01151904
Eligibility Criteria:
Inclusion Criteria:
* Patient has been administering latanoprost eye drops in affected eye(s) for at least 12 weeks prior to study
* Patient must have at least partially responded to latanoprost and requiring further IOP lowering eye drops
* Diagnosis of chronic angle-closure glaucoma
* Patients using COMBIGAN® in the past must not have been discontinued due to adverse events or lack of efficacy.
Exclusion Criteria:
* Known allergy or hypersensitivity to COMBIGAN®
* Corneal abnormalities that would preclude accurate IOP readings
* Any other active ocular disease other than glaucoma or ocular hypertension
* Ocular surgery within the past 3 months.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01151904
Study Brief:
Protocol Section:
NCT01151904